Lin Cheng

机构：Qingdao University, National University of Ireland, Ollscoil na Gaillimhe – University of Galway, Anhui Medical University, Affiliated Hospital of Qingdao University, Second Affiliated Hospital of Anhui Medical University · ORCID：0000-0003-3825-5378

发表论文 217 篇 · 总被引 1995 次 · h-index 24

代表论文

• Distinct cutaneous α-synuclein signatures in body-first and brain-first Parkinson’s disease subtypes (2025 · Brain · 被引 14)
• Coordination-Driven [ c 2]Daisy Chain of Monofunctionalized Tetraphenylethene-Based Hexacationic Cage and Zinc-Porphyrin Toward Photocatalysis-Assisted Photodynamic Therapy (2025 · CCS Chemistry · 被引 8)
• Energy-carbon comprehensive efficiency evaluation of a hydrogen metallurgy system with low-temperature waste heat recovery (2025 · Applied Energy · 被引 7)
• DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment (2025 · BMC Cancer · 被引 4)
• 1325MO Retifanlimab (Anti–PD-1 mAb) alone or in combination with Anti-LAG3 ± Anti-TIM3 mAbs In previously untreated, recurrent and/or metastatic (R/M) PD-L1+ HNSCC: A double-blind randomised controlled phase II trial (2025 · Annals of Oncology · 被引 2)
• Enhanced plasma and brain concentrations and medulloblastoma cytotoxicity of asciminib and nilotinib by P-glycoprotein inhibition with tariquidar (2025 · Anti-Cancer Drugs · 被引 2)